These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 33849019)

  • 1. Outcomes of Adolescents and Young Adults Compared with Children with Acute Leukemia after Single-Unit Unrelated Cord Blood Transplantation Using Myeloablative Conditioning without Antithymocyte Globulin.
    Zhang X; Liu H; Zheng C; Tang B; Zhu X; Wan X; Tong J; Yao W; Song K; Sun Z
    Acta Haematol; 2021; 144(5):569-579. PubMed ID: 33849019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myeloablative Unrelated Cord Blood Transplantation in Adolescents and Young Adults with Acute Leukemia.
    Hayashi H; Volt F; Sanz J; Petersen E; Dhedin N; Hough R; Milpied N; Angelucci E; Yakoub-Agha I; Michallet M; Michel G; Aljurf M; Kenzey C; Rocha V; Dalle JH; Bader P; Ruggeri A; Gluckman E;
    Biol Blood Marrow Transplant; 2019 Dec; 25(12):2438-2446. PubMed ID: 31394275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Umbilical Cord Blood Transplantation without Antithymocyte Globulin Results in Similar Survival but Better Quality of Life Compared with Unrelated Peripheral Blood Stem Cell Transplantation for the Treatment of Acute Leukemia-A Retrospective Study in China.
    Tong J; Xuan L; Sun Y; Huang D; Liu H; Zheng C; Zhu X; Tang B; Song K; Zhang X; Zhang L; Yao W; Lin D; Liu Q; Sun Z
    Biol Blood Marrow Transplant; 2017 Sep; 23(9):1541-1548. PubMed ID: 28499936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-engraftment bloodstream infections in acute leukemia patients undergoing unrelated cord blood transplantation following intensified myeloablative conditioning without ATG.
    Zheng C; Tang B; Zhu X; Zhang X; Zhang L; Geng L; Liu H; Sun Z
    Ann Hematol; 2017 Jan; 96(1):115-124. PubMed ID: 27771742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Better outcomes of modified myeloablative conditioning without antithymocyte globulin versus myeloablative conditioning in cord blood transplantation for hematological malignancies: A retrospective (development) and a prospective (validation) study.
    Sun Z; Liu H; Luo C; Geng L; Zheng C; Tang B; Zhu X; Tong J; Wang X; Ding K; Wan X; Zhang L; Yao W; Song K; Zhang X; Wu Y; Yang H; Han Y; Liu X; Zhu W; Wu J; Wang Z
    Int J Cancer; 2018 Aug; 143(3):699-708. PubMed ID: 29473150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Busulfan/melphalan/antithymocyte globulin followed by unrelated donor cord blood transplantation for treatment of infant leukemia and leukemia in young children: the Cord Blood Transplantation study (COBLT) experience.
    Wall DA; Carter SL; Kernan NA; Kapoor N; Kamani NR; Brochstein JA; Frangoul H; Goyal RK; Horan JT; Pietryga D; Wagner JE; Kurtzberg J;
    Biol Blood Marrow Transplant; 2005 Aug; 11(8):637-46. PubMed ID: 16041314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Favorable Outcome with Conditioning Regimen of Flu/Bu4/Mel in Acute Myeloid Leukemia Patients in Remission Undergoing Cord Blood Transplantation.
    Mizuno S; Takami A; Kawamura K; Shimomura Y; Arai Y; Konuma T; Ozawa Y; Sawa M; Ota S; Takahashi S; Anzai N; Hiramoto N; Onizuka M; Nakamae H; Tanaka M; Murata M; Kimura T; Kanda J; Fukuda T; Atsuta Y; Yanada M
    Transplant Cell Ther; 2022 Nov; 28(11):775.e1-775.e9. PubMed ID: 35921987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-unit umbilical cord blood transplantation from unrelated donors in patients with hematological malignancy using busulfan, thiotepa, fludarabine and ATG as myeloablative conditioning regimen.
    Sanz J; Boluda JC; Martín C; González M; Ferrá C; Serrano D; de Heredia CD; Barrenetxea C; Martinez AM; Solano C; Sanz MA; Sanz GF;
    Bone Marrow Transplant; 2012 Oct; 47(10):1287-93. PubMed ID: 22327127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of rabbit ATG-containing myeloablative conditioning regimens on the outcome of patients undergoing unrelated single-unit cord blood transplantation for hematological malignancies.
    Pascal L; Mohty M; Ruggeri A; Tucunduva L; Milpied N; Chevallier P; Tabrizi R; Labalette M; Gluckman E; Labopin M; Yakoub-Agha I
    Bone Marrow Transplant; 2015 Jan; 50(1):45-50. PubMed ID: 25330221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune reconstitution after single-unit umbilical cord blood transplantation using anti-thymoglobulin and myeloablative conditioning in adults with hematological malignancies.
    Cordón L; Chorão P; Martín-Herreros B; Montoro J; Balaguer A; Guerreiro M; Villalba M; Facal A; Asensi P; Solves P; Gómez I; Santiago M; Lamas B; Bataller A; Granados P; Sempere A; Sanz GF; Sanz MA; Sanz J
    Ann Hematol; 2024 Jul; 103(7):2475-2484. PubMed ID: 38634914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early and Long-Term Impaired T Lymphocyte Immune Reconstitution after Cord Blood Transplantation with Antithymocyte Globulin.
    Castillo N; García-Cadenas I; Barba P; Canals C; Díaz-Heredia C; Martino R; Ferrà C; Badell I; Elorza I; Sierra J; Valcárcel D; Querol S
    Biol Blood Marrow Transplant; 2017 Mar; 23(3):491-497. PubMed ID: 27888015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of conditioning regimens with or without antithymocyte globulin for unrelated cord blood transplantation in children with high-risk or advanced hematological malignancies.
    Zheng C; Luan Z; Fang J; Sun X; Chen J; Li CK; Hu S; Zhu Y; Sun Z
    Biol Blood Marrow Transplant; 2015 Apr; 21(4):707-12. PubMed ID: 25598277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Excellent T-cell reconstitution and survival depend on low ATG exposure after pediatric cord blood transplantation.
    Admiraal R; Lindemans CA; van Kesteren C; Bierings MB; Versluijs AB; Nierkens S; Boelens JJ
    Blood; 2016 Dec; 128(23):2734-2741. PubMed ID: 27702800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of total body irradiation on successful neutrophil engraftment in unrelated bone marrow or cord blood transplantation.
    Nakasone H; Fuji S; Yakushijin K; Onizuka M; Shinohara A; Ohashi K; Miyamura K; Uchida N; Takanashi M; Ichinohe T; Atsuta Y; Fukuda T; Ogata M;
    Am J Hematol; 2017 Feb; 92(2):171-178. PubMed ID: 27880980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Robust CD4+ T-cell recovery in adults transplanted with cord blood and no antithymocyte globulin.
    Politikos I; Lavery JA; Hilden P; Cho C; Borrill T; Maloy MA; Giralt SA; van den Brink MRM; Perales MA; Barker JN
    Blood Adv; 2020 Jan; 4(1):191-202. PubMed ID: 31935291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serious infection risk and immune recovery after double-unit cord blood transplantation without antithymocyte globulin.
    Sauter C; Abboud M; Jia X; Heller G; Gonzales AM; Lubin M; Hawke R; Perales MA; van den Brink MR; Giralt S; Papanicolaou G; Scaradavou A; Small TN; Barker JN
    Biol Blood Marrow Transplant; 2011 Oct; 17(10):1460-71. PubMed ID: 21310254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single- vs double-unit cord blood transplantation for children and young adults with acute leukemia or myelodysplastic syndrome.
    Michel G; Galambrun C; Sirvent A; Pochon C; Bruno B; Jubert C; Loundou A; Yakoub-Agha I; Milpied N; Lutz P; Marie-Cardine A; Gandemer V; Blaise D; Michallet M; Rialland F; Renard C; Oudin C; Esmiol S; Seux M; Baumstarck K; Mohty M; Rocha V; Dalle JH
    Blood; 2016 Jun; 127(26):3450-7. PubMed ID: 27099151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cord blood transplantation from unrelated donors in adults with high-risk acute myeloid leukemia.
    Sanz J; Sanz MA; Saavedra S; Lorenzo I; Montesinos P; Senent L; Planelles D; Larrea L; Martín G; Palau J; Jarque I; Martínez J; de la Rubia J; Moscardó F; Romero M; Luna I; Montava A; Cañabate S; Sanz GF
    Biol Blood Marrow Transplant; 2010 Jan; 16(1):86-94. PubMed ID: 19744570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unrelated cord blood transplantation after myeloablative conditioning in adults with acute myelogenous leukemia.
    Ooi J; Takahashi S; Tomonari A; Tsukada N; Konuma T; Kato S; Kasahara S; Sato A; Monma F; Nagamura F; Iseki T; Tojo A; Asano S
    Biol Blood Marrow Transplant; 2008 Dec; 14(12):1341-7. PubMed ID: 19041055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Durable Chimerism and Long-Term Survival after Unrelated Umbilical Cord Blood Transplantation for Pediatric Hemophagocytic Lymphohistiocytosis: A Single-Center Experience.
    Patel SA; Allewelt HA; Troy JD; Martin PL; Driscoll TA; Prasad VK; Kurtzberg J; Page KM; Parikh SH
    Biol Blood Marrow Transplant; 2017 Oct; 23(10):1722-1728. PubMed ID: 28647558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.